3,611,815 new COVID-19 cases in the last 7 days in the USA .....
..... the sheer trajectory of these COVID-19 case numbers is alarming enough but when combined with the increase in hospitalizations IMO these statistics could be used as RWE by Mesoblast when they discuss funding requirements with maybe the NIH or a new partner for their planned 2nd COVID-19 ARDS trial in the USA using Remestemcel-L ?
Texas and Florida are classic examples of states that have been using monoclonal antibodies and other latest FDA approved COVID-19 treatments for months and yet sadly they are still in all sorts of trouble according to the articles below
If this situation continues to deteriorate in the USA, you would hope at some point either BARDA or the NIH would once again intervene ? Who knows, but it is time to get this additional trial underway if Remestemcel-L can actually help save lives because we are entering the 3rd year of this pandemic FGS
GLTAH
https://www.worldometers.info/coronavirus/weekly-trends/#weekly_table
https://www.theguardian.com/us-news/2022/jan/03/us-covid-omicron-coronavirus-cases-florida
Covid cases rise by 948% in Florida as Omicron drives huge wave across US
Seven-day average for hospitalizations increased by more than 40% during week between Christmas and New Year’s Eve
https://www.kxan.com/news/texas/tex...g-shortages-as-covid-hospitalizations-double/
Texas hospitals face staffing shortages as COVID hospitalizations double
- Forums
- ASX - By Stock
- RWE for 2nd MSB COVID-19 ARDS P3 Trial
3,611,815 new COVID-19 cases in the last 7 days in the USA...
- There are more pages in this discussion • 904 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.26 |
Change
0.105(9.09%) |
Mkt cap ! $1.438B |
Open | High | Low | Value | Volume |
$1.16 | $1.30 | $1.16 | $21.76M | 17.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 98636 | $1.26 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.26 | 600000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | 1.300 |
1 | 2000 | 1.280 |
1 | 347 | 1.275 |
1 | 50000 | 1.270 |
1 | 700 | 1.265 |
Price($) | Vol. | No. |
---|---|---|
1.235 | 239 | 1 |
1.245 | 5000 | 1 |
1.250 | 3000 | 1 |
1.260 | 30000 | 1 |
1.270 | 183 | 2 |
Last trade - 16.10pm 28/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.27 |
  |
Change
0.105 ( 9.35 %) |
|||
Open | High | Low | Volume | ||
$1.17 | $1.30 | $1.16 | 2142493 | ||
Last updated 15.59pm 28/05/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online